China NT Pharma Group Co., Ltd.'s total assets for Q2 2024 were ¥338.76M, a decrease of -67.90% from the previous quarter. HK:1011 total liabilities were ¥685.18M for the fiscal quarter, a -47.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.